Improving nutrition before surgery for patients with inflammatory bowel disease
Official title: Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
Run by NYU Langone Health · NCT06309017 · Data updated 2026-11-12
This study tests if better nutrition before surgery can help people with inflammatory bowel disease recover faster and have fewer complications after their operation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | January 7, 2025 |
| Main results expected | January 2027 |
| Study ends | July 2027 |
| Registry record updated | March 5, 2026 |
| Trial ID | NCT06309017 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a confirmed diagnosis of inflammatory bowel disease scheduled for intestinal resection surgery.
✕Probably not a fit
Patients without a diagnosis of inflammatory bowel disease or those under 18 years old will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates whether enhanced nutritional support and risk assessment can reduce postoperative complications in patients undergoing surgery for inflammatory bowel disease (IBD). It focuses on preoperative screening for malnutrition and the use of immune modulation nutrition to improve surgical outcomes. The primary goal is to determine if these interventions can minimize complications and length of hospital stay following surgery. Participants will receive specialized nutrition interventions, including immunonutrition shakes, to support their recovery.
Why it matters
Potential benefit: If successful, this approach could significantly reduce postoperative complications and improve recovery times for patients with inflammatory bowel disease.
How similar studies have gone: Other studies have shown promising results with nutritional interventions in surgical patients, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Able and willing to provide written informed consent 2. Aged 18 years of age or older 3. Confirmed diagnosis of inflammatory bowel disease 4. Scheduled for disease-related intestinal resection at NYU Langone Health Exclusion Criteria: 1. No current diagnosis of inflammatory bowel disease 2. Age less than 18 3. Not proficient (able to read and answer questions) in English
Where it's running
-
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Jennifer Katz, MD — NYU Langone Health
- Study coordinator: Jennifer Katz, MD
- Email: Jennifer.katz@nyulangone.org
- Phone: (855) 698-4232
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-Term Guselkumab Use in Adults with Inflammatory Bowel Disease
This study looks at how long adults with Crohn's disease or ulcerative colitis stay on guselkumab in real-world care.
-
Intestinal ultrasound-guided management for inflammatory bowel disease
This study tests if adding point-of-care intestinal ultrasound at every visit changes treatment decisions for adults with Crohn’s disease or ulcerative colitis undergoing disease assessment.
-
Resting energy use in kids with inflammatory bowel disease
This multicenter study will test the resting energy expenditure of children aged 6–17 with new IBD diagnoses to see how it relates to disease activity and treatment.
-
Active video education by disease subtype to improve bowel prep before colonoscopy
We’re testing whether adding subtype-specific video education to standard prep improves bowel cleanliness in adults with IBD undergoing colonoscopy.
-
Intestinal ultrasound to predict relapse in Crohn's disease patients in deep remission.
This project will try to see if a noninvasive transabdominal ultrasound can predict relapses in adults with Crohn's disease who are currently in deep remission.
-
Ath-063: Testing a new treatment for moderately to severely active ulcerative colitis in patients who have tried other biologics
This study tests ATH-063 to see if it helps people with moderate to severe ulcerative colitis who did not respond to or relapsed after prior biologic therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.